Categories: Mental health

Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study

Background

Psychiatric comorbidity is frequent among persons with attention-deficit/hyperactivity disorder (ADHD). Whether pharmacological treatment of ADHD influences the incidence of psychiatric comorbidity is uncertain.


Objective

To investigate associations and causal relations between pharmacological treatment of ADHD and incidence of subsequent comorbid psychiatric diagnoses.


Methods

We employed registry data covering all individuals aged 5–18 years in Norway who were diagnosed with ADHD during 2009–2011 (n=8051), followed until 2020. We used linear probability models (LPM) and instrumental variable (IV) analyses to examine associations and causal effects, respectively, between pharmacological treatment and subsequent comorbidity.


Findings

From time of ADHD diagnosis to 9 years of follow-up, 63% of patients were registered with comorbid psychiatric disorders. For males, LPM showed associations between ADHD medication and several incident comorbidities, but strength and direction of associations and consistency over time varied. For females, no associations were statistically significant. IV analyses for selected categories isolating effects among patients ‘on the margin of treatment’ showed a protective effect for a category of stress-related disorders in females and for tic disorders in males for the first 2 and 3 years of pharmacological treatment, respectively.


Conclusions

Overall, LPM and IV analyses did not provide consistent or credible support for long-term effects of pharmacological treatment on later psychiatric comorbidity. However, IV results suggest that for patients on the margin of treatment, pharmacological treatment may initially reduce the incidence of certain categories of comorbid disorders.


Clinical implications

Clinicians working with persons with ADHD should monitor the effects of ADHD medication on later psychiatric comorbidity.


Trial registration number

ISRCTN11891971.

prince

Share
Published by
prince

Recent Posts

Best Air Purifiers in the UK for Managing Asthma

I’ve been toying with the idea of getting an air purifier for my home for…

1 week ago

Minimally important change on the Columbia Impairment Scale and Strengths and Difficulties Questionnaire in youths seeking mental healthcare

Background Evidence-based mental health requires patient-relevant outcome data, but many indicators lack clinical meaning and…

1 week ago

Multigenerational family coaggregation study of obsessive-compulsive disorder and cardiometabolic disorders

Background Obsessive-compulsive disorder (OCD) is associated with an increased risk of morbidity and mortality due…

2 weeks ago

Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines

Objectives Should a young person receive psychotherapy or medication for their depression and on what…

2 weeks ago